Mayer S - Search Results

1

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.

Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A; CONSCIOUS-1 Investigators. Macdonald RL, et al. Among authors: mayer s. Stroke. 2008 Nov;39(11):3015-21. doi: 10.1161/STROKEAHA.108.519942. Epub 2008 Aug 7. Stroke. 2008. PMID: 18688013 Clinical Trial.

2

Myocardial injury and left ventricular performance after subarachnoid hemorrhage.

Mayer SA, Lin J, Homma S, Solomon RA, Lennihan L, Sherman D, Fink ME, Beckford A, Klebanoff LM. Mayer SA, et al. Stroke. 1999 Apr;30(4):780-6. doi: 10.1161/01.str.30.4.780. Stroke. 1999. PMID: 10187879

3

Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial.

Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA. Lennihan L, et al. Among authors: mayer sa. Stroke. 2000 Feb;31(2):383-91. doi: 10.1161/01.str.31.2.383. Stroke. 2000. PMID: 10657410 Clinical Trial.

4

Predictors of cognitive dysfunction after subarachnoid hemorrhage.

Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J, Du YE, Stern Y, Connolly ES, Mayer SA. Kreiter KT, et al. Among authors: mayer sa. Stroke. 2002 Jan;33(1):200-8. doi: 10.1161/hs0102.101080. Stroke. 2002. PMID: 11779911

5

Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome.

Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Claassen J, et al. Stroke. 2002 May;33(5):1225-32. doi: 10.1161/01.str.0000015624.29071.1f. Stroke. 2002. PMID: 11988595

6

Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.

Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T; Europe/AustralAsia NovoSeven ICH Trial Investigators. Mayer SA, et al. Stroke. 2005 Jan;36(1):74-9. doi: 10.1161/01.STR.0000149628.80251.b8. Epub 2004 Nov 29. Stroke. 2005. PMID: 15569871 Clinical Trial.

7

Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage.

Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF. Naidech AM, et al. Stroke. 2005 Mar;36(3):583-7. doi: 10.1161/01.STR.0000141936.36596.1e. Epub 2005 Jan 20. Stroke. 2005. PMID: 15662039

8

Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale.

Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, MacDonald RL, Mayer SA. Frontera JA, et al. Neurosurgery. 2006 Jul;59(1):21-7; discussion 21-7. doi: 10.1227/01.neu.0000243277.86222.6c. Neurosurgery. 2006. PMID: 16823296

9

Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.

Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, Broderick JP. Diringer MN, et al. Stroke. 2008 Mar;39(3):850-6. doi: 10.1161/STROKEAHA.107.493601. Epub 2008 Jan 31. Stroke. 2008. PMID: 18239180

10

Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage.

Starke RM, Kim GH, Fernandez A, Komotar RJ, Hickman ZL, Otten ML, Ducruet AF, Kellner CP, Hahn DK, Chwajol M, Mayer SA, Connolly ES Jr. Starke RM, et al. Stroke. 2008 Sep;39(9):2617-21. doi: 10.1161/STROKEAHA.107.506097. Epub 2008 Jul 24. Stroke. 2008. PMID: 18658042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,736 results

Search Page